China Medical System (00867 HK) MSCI-ESG Rating Upgraded to AA, Reaching Global Level – IT Business Net itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.
Tuesday, 22 December 2020, 4:02 pm
Morgan Stanley Capital International (MSCI) issued a
report on December 17 upgrading the ESG (Environmental,
Social and Governance) Rating for China Medical System
Holdings Limited ( China Medical System ), a
well-established, innovation-driven specialty pharma with a
focus on sales & marketing in China. China Medical
System s ESG Rating has been upgraded from BBB to AA ,
surpassing 88% of companies in the global pharmaceutical
industry, symbolizing that the Company has attained a level
among its global peers in ESG management.
MSCI
recognized China Medical System s outstanding performance in
Corporate Governance, Corporate Behavior, Product Safety and
Quality, Human Capital Development, and Access to Health
China Medical System (00867.HK) MSCI-ESG Rating Upgraded to AA , Reaching a Leading Global Level
BriefingWire.com, 12/21/2020 - On December 17, the largest index provider, Morgan Stanley Capital International (MSCI) updated a report on the ESG (Environmental, Social and Governance) rating for China Medical System Holdings Limited ( China Medical System ), a well-established, innovation-driven specialty pharma with a focus on sales & marketing in China. According to the report, China Medical System s ESG rating has been upgraded from BBB to AA , surpassing 88% of companies in the global pharmaceutical industry, and symbolizing that the Company has reached a leading level among its global peers in ESG management.